MedTrace Logo

Destiny: D-dimer. Investigating D-dimer Levels Using Point-of-Care (POC) Testing at Primary Care.

NCT05109260 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2021-11-05

No results posted yet for this study

Summary

DESTINY D-Dimer is an observational feasibility study, and a collaboration between the University of South Wales and Cwm Taf Morgannwg University Health Board (CTMUHB). The study is based at St. John's Medical Practice in Aberdare, where participant recruitment will take place. Blood D-dimer data will be collected from CTMUHB Pathology Laboratory services, at Prince Charles Hospital. Study blood samples will be obtained by the research student, LAH, under the direction of Dr Owen Thomas at St John's Medical Centre. The participant data will be collected by the research student who will conduct a Wells' Risk Score and perform D-dimer POC tests to generate quantitative data. Data will later be compared by the research student with the diagnoses obtained from Secondary Care at Prince Charles Hospital via analysis of medical records to include a laboratory generated D-Dimer results and additional diagnostics (eg. Doppler).

A laboratory based analytical verification of D-dimer POC tests will be undertaken to compare with the current laboratory method. The study will compare the data from the D-dimer POC tests and those gained using laboratory methods at Prince Charles Hospital.

Conditions

  • Deep Vein Thrombosis

Interventions

DIAGNOSTIC_TEST

Point-of-Care Immunoassay device

2 POC Immunoassay devices will be used. One will measure D-dimer levels in capillary blood, the other will measure venous.

Sponsors & Collaborators

  • University of South Wales

    lead OTHER

Principal Investigators

  • Mark Williams, BSc, PhD · Director of Studies and Chief investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-26
Primary Completion
2022-09-01
Completion
2023-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05109260 on ClinicalTrials.gov